首頁 > 市場調查報告書 > 製藥

生技設備生物工藝

市場調查報告書

商品編碼

2078905

生物程序驗證市場：按測試類型、製程組件、最終用戶和地區分類。

Bioprocess Validation Market, By Test Type, By Process Component, By End User, By Geography

出版日期: 2026年04月29日 | 出版商:

Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，生物製程驗證市場規模將達到 6.097 億美元，到 2033 年將達到 11.806 億美元。預計從 2026 年到 2033 年，該市場將以 9.9% 的複合年成長率成長。

分析範圍		分析詳情
基準年	2025	市場規模（2026 年）	6.097億美元
效能數據	2020-2024	預測期	2026-2033
預測期（2026-2033 年）複合年成長率	9.90%	預計金額（2033 年）	11.806億美元

生物製程檢驗是指從設計階段到商業化生產，收集和評估數據，以科學地證明該製程能夠持續生產高品質產品。這是生物製藥生產的監管要求。近年來，受生物製藥和單株抗體需求不斷成長的推動，生物製程驗證市場經歷了顯著成長。生物製藥已徹底改變了各個治療領域的患者照護和治療。隨著生物製藥獲準數量和產量的增加，為確保這些複雜分子的品質、療效和安全性而進行的驗證活動也日益加強。包括美國食品藥物管理局（FDA）在內的監管機構已製定了嚴格的生物製程驗證法規，這進一步推動了市場成長。

市場動態：

生物製程驗證市場的成長受到多種因素的驅動，這些因素共同塑造了產業格局。其中一個主要促進因素是生物製藥需求的不斷成長。隨著癌症和自體免疫疾病等慢性疾病的日益普遍，先進的生物製藥產品不斷湧現，這需要強力的生物製程驗證策略。

推動市場成長的另一個因素是美國食品藥物管理局(FDA) 和歐洲藥品管理局 (EMA) 等監管機構實施的嚴格規定。這些規定要求生物製藥生產商證明其生產流程的有效性和一致性，從而推動了對生物製程驗證的需求。

此外，市場參與者擴大採用收購等非內生成長策略，預計也將推動全球生物製程驗證市場在預測期內的成長。例如，2020年4月，生命科學和診斷領域的全球創新者丹納赫公司收購了通用電氣（GE）的生命科學生物製程業務，包括層析法系統，以增強其生物製藥開發和生產解決方案能力。

然而，該市場也面臨諸多限制因素。生物製程的複雜性以及缺乏標準化的驗證方案是其面臨的挑戰。生物製程的開發和驗證耗時費力，需要大量的資源和基礎設施投入。此外，具備生物程序驗證專業知識的熟練人員短缺也進一步阻礙了市場成長。

儘管面臨這些挑戰，市場仍蘊藏著許多成長機會。生物製程自動化和數據分析技術的進步有望簡化驗證流程，從而降低成本並提高效率。此外，對個人化醫療的日益重視以及生物程序中一次性技術的廣泛應用，也為市場擴張開闢了新的途徑。

本報告的主要特點

本報告揭示了各個細分市場的潛在商機，並描述了該市場中一系列有吸引力的投資提案。
此外，它還提供了有關市場促進因素和限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要公司採取的競爭策略的重要見解。
本報告中的見解將使負責人和企業經營團隊能夠就未來的產品發布、技術更新、市場擴張和行銷策略做出明智的決策。
《全球生物製程驗證市場》報告面向該產業的眾多相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過分析全球生物製程驗證市場中使用的各種策略矩陣來促進決策。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
中東和非洲
- 海灣合作理事會國家
- 以色列
- 南非
- 北非
- 中非
- 其他中東國家

第8章競爭情勢

Sartorius Stedim Biotech
Merck KGaA
Pall Corporation
Cobetter Filtration Equipment
Toxikon Corporation
DOC Srl
Meissner Filtration Test Types
Thermo Fisher Scientific
SGS SA
Eurofins Scientific
Lonza Group
ProBioGen AG
Charles River Laboratories
Pacific BioLabs
Gibraltar Laboratories
Nelson Laboratories
BioProcess Technology Consultants
CMIC HOLDINGS Co., Ltd
Cytovance Biologics
Wuxi Biologics

第9章

分析方法
關於 Coherent Market Insights

簡介目錄

Product Code: CMI6287

Bioprocess Validation Market is estimated to be valued at USD 609.7 Mn in 2026 and is expected to reach USD 1,180.6 Mn by 2033, growing at a compound annual growth rate (CAGR) of 9.9% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 609.7 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	9.90%	2033 Value Projection:	USD 1,180.6 Mn

Bioprocess validation is the collection and evaluation of data, from the design stage through commercial production, which establishes scientific evidence that a process is capable of consistently delivering quality product. It is a regulatory requirement for biopharmaceuticals manufacturing. The bioprocess validation market has been witnessing significant growth in recent years driven by the increasing demand for biologics and monoclonal antibodies. Biologics have revolutionized patient care and treatments across various therapeutic areas. Rising biologics approvals and production have been propelling validation activities to guarantee the quality, efficacy, and safety of such complex molecules. Various regulatory agencies including the U.S. Food and Drug Administration (U.S. FDA) have stringent regulations for bioprocess validation, facilitating the growth of this market.

Market Dynamics:

The bioprocess validation market growth is driven by various factors that are shaping the industry landscape. One of the primary drivers is the increasing demand for biopharmaceutical products. The growing prevalence of chronic diseases, such as cancer and autoimmune disorders, has led to the development of advanced biologics, thereby creating a need for robust bioprocess validation strategies.

Another factor contributing to market growth is the stringent regulations imposed by regulatory authorities, such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). These regulations require biopharmaceutical manufacturers to demonstrate the effectiveness and consistency of their manufacturing processes, driving the demand for bioprocess validation.

Moreover, the increasing adoption of inorganic activities such as acquisition by the market players is expected to drive the growth of the global bioprocess validation market over the forecast period. For instance, in April 2020, Danaher Corporation, a global life sciences and diagnostic innovator, acquired the bioprocessing business from General Electric's life sciences division, including chromatography systems, to enhance biologics development and manufacturing solutions.

However, the market does face some restraints. The complex nature of bioprocessing and the lack of standardized validation protocols pose challenges. The development and validation of bioprocesses are time-consuming and require substantial investments in terms of resources and infrastructure. Additionally, the scarcity of skilled professionals with expertise in bioprocess validation further impedes market growth.

Despite these challenges, the market experiences several opportunities for growth. Technological advancements in bioprocess automation and data analytics are anticipated to streamline the validation process, reducing costs and enhancing efficiency. Furthermore, the increasing focus on personalized medicine and the rising adoption of single-use technologies in bioprocessing offer new avenues for the market expansion.

Key features of the study:

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
Key companies covered as a part of this study include Sartorius Stedim Biotech, Merck KGaA, Pall Corporation, Cobetter Filtration Equipment, Toxikon Corporation, DOC S.r.l., MEISSNER FILTRATION PRODUCTS, Thermo Fisher Scientific, SGS SA, Eurofins Scientific, Lonza Group, ProBioGen AG, Charles River Laboratories, Pacific BioLabs, Gibraltar Laboratories, Nelson Laboratories, BioProcess Technology Consultants, CMIC HOLDINGS Co., Ltd, Cytovance Biologics, and Wuxi Biologics.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global bioprocess validation market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global bioprocess validation market.

Bioprocess Validation Market Segmentation:

By Test Type (Revenue, USD Mn, 2021 - 2033)
Extractable Testing Services
Microbiological Testing Services
Physiochemical Testing Services
Integrity Testing Services
Others (Compatibility Testing Services and Others)
By Process Component (Revenue, USD Mn, 2021 - 2033)
Filter Elements
Media containers and bags
Freezing And Thawing Process Bags
Bioreactors
Transfer Systems
Others (Mixing Systems and Others)
By End User (Revenue, USD Mn, 2021 - 2033)
Pharmaceutical & Biotechnology Companies
Contract Development & Manufacturing Organizations
Academic and Research Institutes
Other (Clinical Research Organizations and Others)
Regional Insights (Revenue, USD Mn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Top Companies in Bioprocess Validation Market:
Sartorius Stedim Biotech
Merck KGaA
Pall Corporation
Cobetter Filtration Equipment
Toxikon Corporation
DOC S.r.l.
MEISSNER FILTRATION PRODUCTS
Thermo Fisher Scientific
SGS SA
Eurofins Scientific
Lonza Group
ProBioGen AG
Charles River Laboratories
Pacific BioLabs
Gibraltar Laboratories
Nelson Laboratories
BioProcess Technology Consultants
CMIC HOLDINGS Co., Ltd
Cytovance Biologics
Wuxi Biologics

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Bioprocess Validation, By Test Type
- Market Bioprocess Validation, By Process Component
- Market Bioprocess Validation, By End User
- Market Bioprocess Validation, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
  - Increasing demand for biopharmaceutical products
- Restraints
  - Complex nature of bioprocessing
- Opportunities
  - Technological advancements in bioprocess automation and data analytics
Impact Analysis
Key Highlights
Regulatory Scenario
Test Type launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Bioprocess Validation Market , By Test Type, 2021 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Extractable Testing Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
Microbiological Testing Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
Physiochemical Testing Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
Integrity Testing Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
Others (Compatibility Testing Services and Others)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)

5. Global Bioprocess Validation Market , By Process Component, 2021 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
Filter Elements
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
Media containers and bags
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
Freezing And Thawing Process Bags
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
Bioreactors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
Transfer Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
Others (Mixing Systems and Others)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)

6. Global Bioprocess Validation Market , By End User, 2021 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
Pharmaceutical & Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
Contract Development & Manufacturing Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
Other (Clinical Research Organizations and Others)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)

7. Global Bioprocess Validation Market , By Region, 2021 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, By Country, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Country 2022-2033
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Process Component, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Process Component, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Process Component, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Process Component, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Process Component, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
  - GCC Countries
  - Israel
  - South Africa
  - North Africa
  - Central Africa
  - Rest of Middle East

8. Competitive Landscape

Sartorius Stedim Biotech
- Company Highlights
- Test Type Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck KGaA
- Company Highlights
- Test Type Portfolio
- Key Highlights
- Financial Performance
- Strategies
Pall Corporation
- Company Highlights
- Test Type Portfolio
- Key Highlights
- Financial Performance
- Strategies
Cobetter Filtration Equipment
- Company Highlights
- Test Type Portfolio
- Key Highlights
- Financial Performance
- Strategies
Toxikon Corporation
- Company Highlights
- Test Type Portfolio
- Key Highlights
- Financial Performance
- Strategies
DOC S.r.l.
- Company Highlights
- Test Type Portfolio
- Key Highlights
- Financial Performance
- Strategies
Meissner Filtration Test Types
- Company Highlights
- Test Type Portfolio
- Key Highlights
- Financial Performance
- Strategies
Thermo Fisher Scientific
- Company Highlights
- Test Type Portfolio
- Key Highlights
- Financial Performance
- Strategies
SGS SA
- Company Highlights
- Test Type Portfolio
- Key Highlights
- Financial Performance
- Strategies
Eurofins Scientific
- Company Highlights
- Test Type Portfolio
- Key Highlights
- Financial Performance
- Strategies
Lonza Group
- Company Highlights
- Test Type Portfolio
- Key Developments
- Financial Performance
- Strategies
ProBioGen AG
- Company Highlights
- Test Type Portfolio
- Key Highlights
- Financial Performance
- Strategies
Charles River Laboratories
- Company Highlights
- Test Type Portfolio
- Key Highlights
- Financial Performance
- Strategies
Pacific BioLabs
- Company Highlights
- Test Type Portfolio
- Key Highlights
- Financial Performance
- Strategies
Gibraltar Laboratories
- Company Highlights
- Test Type Portfolio
- Key Highlights
- Financial Performance
- Strategies
Nelson Laboratories
- Company Highlights
- Test Type Portfolio
- Key Highlights
- Financial Performance
- Strategies
BioProcess Technology Consultants
- Company Highlights
- Test Type Portfolio
- Key Highlights
- Financial Performance
- Strategies
CMIC HOLDINGS Co., Ltd
- Company Highlights
- Test Type Portfolio
- Key Highlights
- Financial Performance
- Strategies
Cytovance Biologics
- Company Highlights
- Test Type Portfolio
- Key Highlights
- Financial Performance
- Strategies
Wuxi Biologics
- Company Highlights
- Test Type Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views